As informatic technology becomes increasingly important in drug R&D, the
application of bioinformatics/ informatics applications has the potential to
drive growth in the worldwide pharmaceuticals drug market from the $240 billion
today to $3 trillion by 2020.
The forecast value for the worldwide informatics market in the life science
sector is between $1.7 and $7 billion by 2007. Biotechnology and pharmaceutical
companies are set to continue the recent trend of purchasing content and
informatic solutions from commercial vendors.
Why you must buy this report:
With more than 25 tables, 17 graphs, visiongain's survey of industry experts,
and detailed profiles of 16 leading companies that incorporate, provide and
develop innovative informatic tools and technologies, can you afford to be
without this new visiongain report?
Despite recent closures of bioinformatic companies such as DoubleTwist, the
life science informatics marketplace is set to expand as high-tech companies
infiltrate this market area and biopharmaceutical companies incorporate key
informatic solutions into their business strategy.
This new visiongain report provides you with the most detailed and up-to-date
analysis, news, developments, experts' opinions and insight into the informatics
market.
Key questions answered in this report:
- How can informatic tools and technologies facilitate drug discovery,
design and development?
- What are the main types of informatic technologies that are currently
available?
- Who are the current key players in this marketplace?
- Which life science informatics market areas have the greatest potential
for growth?
- What is the current state of the bioinformatics market?
- Which biotechnology and pharmaceutical companies are investing in
informatics solutions?
- What are the main informatics business strategies adopted by leading
companies?
- What are the benefits of informatics?
View Cart
